导管,经皮,心脏消融,用于治疗心房颤动
PMA编号:P040042 · 2026-09-03
广告
器械摘要
常见问题
What is the catheter, percutaneous, cardiac ablation, for treatment of atrial flutter?
catheter, percutaneous, cardiac ablation, for treatment of atrial flutter is a medical device that received FDA 510(k) clearance on 2026-09-03. The listed applicant is Irvine Biomedical,Inc.(Ibi).
When did catheter, percutaneous, cardiac ablation, for treatment of atrial flutter receive FDA 510(k) clearance?
The clearance date for catheter, percutaneous, cardiac ablation, for treatment of atrial flutter can be found in the official FDA records.
谁是用于治疗心房颤动的心导管、经皮、心脏消融术的列名申请人?
The FDA 510(k) record lists Irvine Biomedical,Inc.(Ibi) as the applicant. This does not by itself establish the device manufacturer.
FDA导管、经皮、心脏消融产品代码是什么,用于治疗心房颤动?
FDA产品代码为导管、经皮、心脏消融,用于治疗房颤的是OAD。
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告